China is in a global race to develop cost-effective vaccines to stem the COVID-19 pandemic.
Beijing:
China has approved human testing for a potential vaccine against the coronavirus grown in insect cells, local government in southwestern Chengdu city said on Saturday.
China is in a global race to develop cost-effective vaccines to stem the COVID-19 pandemic.
Using insect cells to grow proteins for the coronavirus vaccine – a first in China – could speed up large-scale production, the Chengdu city government said in a WeChat social media notice.
The vaccine, developed by the West China Hospital of Sichuan University in Chengdu, has received approval from the National Medicines Administration for entry into a clinical trial, according to the notice.
When tested in monkeys, the vaccine was shown to prevent SARS-CoV-2 infections without obvious side effects, the advisory added.
Chinese scientists are already leading work on at least eight other potential coronavirus vaccines that have entered various stages of clinical trials.
Foreign players, including BioNTech in Germany and Inovio Pharma in the United States, have also cooperated with local companies to test their investigational vaccines in China.
(This story was not edited by GalacticGaming staff and is auto-generated from a syndicated feed.)
